Google (Google DeepMind / Isomorphic Labs)

Isomorphic Labs is an AI-first drug discovery company and an autonomous subsidiary of Alphabet Inc. Spun out from Google DeepMind in 2021, the company leverages the Nobel Prize-winning AlphaFold technology to reimagine the drug discovery process. It focuses on building predictive and generative AI models to understand biological mechanisms and design novel therapeutics at digital speed. The company operates at the intersection of machine learning and the life sciences, aiming to transition drug discovery from a trial-and-error laboratory process to a predictive, digital-first discipline. By modeling the interactions of proteins, DNA, RNA, and ligands, Isomorphic Labs seeks to unlock 'undruggable' targets and drastically shorten the timeline for bringing new medicines to clinical trials.